The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 05, 2024

Filed:

May. 03, 2022
Applicant:

Yeda Research and Development Co. Ltd., Rehovot, IL;

Inventors:

Yair Reisner, Houston, TX (US);

Yaki Eidelstein, Rehovot, IL;

Eran Ophir, Rehovot, IL;

Assaf Lask, Rehovot, IL;

Ran Afik, Rehovot, IL;

Noga Or-Geva, Rehovot, IL;

Esther Bachar-Lustig, Rehovot, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 35/12 (2015.01); A61K 35/22 (2015.01); A61K 35/26 (2015.01); A61K 35/28 (2015.01); A61K 35/34 (2015.01); A61K 35/36 (2015.01); A61K 35/38 (2015.01); A61K 35/39 (2015.01); A61K 35/407 (2015.01); A61K 35/42 (2015.01); A61K 39/00 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 35/22 (2013.01); A61K 35/26 (2013.01); A61K 35/28 (2013.01); A61K 35/34 (2013.01); A61K 35/36 (2013.01); A61K 35/38 (2013.01); A61K 35/39 (2013.01); A61K 35/407 (2013.01); A61K 35/42 (2013.01); A61K 39/001 (2013.01); C12N 5/0636 (2013.01); C12N 5/0637 (2013.01); A61K 2035/122 (2013.01); A61K 2035/124 (2013.01); A61K 2039/5158 (2013.01); C12N 2501/2307 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/2321 (2013.01); C12N 2502/1121 (2013.01);
Abstract

A method of generating an isolated population of cells comprising anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance-inducing cells and/or endowed with anti-disease activity, and capable of homing to the lymph nodes following transplantation is disclosed. The method comprising: (a) contacting peripheral blood mononuclear cells (PBMC) with a third party antigen or antigens in the presence of IL-21 so as to allow enrichment of antigen reactive cells; and (b) culturing the cells resulting from step (a) in the presence of IL-21, IL-15 and IL-7 in an antigen free environment so as to allow proliferation of cells comprising the central memory T-lymphocyte (Tcm) phenotype.


Find Patent Forward Citations

Loading…